-
Being under ever-increasing pressure to compete in a challenging economic and technological environment, pharmaceutical and biotech companies must continually innovate in their R&D programmes to stay ahead of the game. External innovations come in different forms and originate in diffe...Read more »
-
According to a study published in Cell, researchers have developed a specific inhibitor for KRASG12C called ARS-1602 that induced tumor regression in mice. “This study provides in vivo evidence that mutant KRAS can be selectively targeted, and reveals ARS-1620 as representing a new generation of ...Read more »
-
AstraZeneca received a double boost for its oncology portfolio on Tuesday, after US and European regulators accepted regulatory submissions for its drugs, the first step towards winning approval for these medicines. The Anglo-Swedish drugmaker, and MedImmune, its global biologics research and de...Read more »
